BioHealth News
Issue Brief: March-In Rights Under the Bayh-Dole Act (February 2023)
The biggest controversy surrounding the Bayh-Dole Act — which allows academic institutions and private contractors to own and manage inventions they make with federal funds…
Read MoreApogeeBio Postdoctoral Programme
Dear scientific community, The European programme ApogeeBio has launched the 2nd international call for 12 postdoctoral positions in Genopole biocluster, Paris region (FR). It…
Read MoreBaltimore’s KaloCyte Partners on $46M DARPA Program to Develop Synthetic Blood Product · BioBuzz
KaloCyte’s experimental synthetic red blood cell product ErythroMer could provide a solution to the high need for treating trauma in both military and civilian…
Read MorePhlow Corp. Announces Formation of Business Advisory Board, New Board of Directors Appointment and Corporate President as Company Accelerates Towards Next Stage of Growth
Richmond, Virginia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based public benefit corporation leveraging advanced manufacturing processes to re-imagine the domestic production…
Read MoreCanon posts record revenues in medical business unit
Stronger sales in Europe and the U.S. helped offset declining demand in Japan for the Medical Business Unit of Japanese industrial conglomerate Canon for…
Read MoreCartesian Therapeutics Announces Dosing of First Participant in a Phase 2b Randomized Clinical Trial for Generalized Myasthenia Gravis – Cartesian
⦁ First placebo-controlled study of an engineered cell therapy Gaithersburg, MD, January 31, 2023 – Cartesian Therapeutics, a fully integrated, clinical-stage biotechnology company pioneering…
Read MoreAURP BIO Health Caucus 2023
AURP’s BioHealth Caucus will examine topics, including: Economic impact of the biotech industry in the U.S. New biotech hubs growing in VA, NC, OK,…
Read MoreMontgomery County Perfect Home for ARPA-H
The newly established Advanced Research Projects Agency for Health (ARPA-H) will accelerate cutting-edge biomedical and health research, moving discoveries from the laboratory to patients…
Read MoreTEDCO chooses 24 MD companies for SBIR/STTR Proposal Lab cohort
TEDCO, Maryland’s economic engine for technology companies, Tuesday announced the selection of 24 Maryland companies to participate in the FY2023 FAST SBIR/STTR Proposal Lab cohort. This program, now…
Read MoreWJLA: Maryland’s Medcura Recognized For Innovative Biosurgical Tech (Video)
Prince George's County, Maryland based Medcura’s is pioneering a proprietary biosurgical technology that has repeatedly demonstrated the rapid arrest of difficult-to-control surgical bleeding. With…
Read MoreQuality Biological Inks 24,000 SF Lease at Shady Grove Development Park in Gaithersburg, MD
GAITHERSBURG, M.D. – Transwestern Real Estate Services (TRS) announces Quality Biological, Inc. has signed a 24,000-square-foot lease at Shady Grove Development Park, a 745,000-square-foot, 10-building mixed-use project…
Read MoreTonix Pharmaceuticals Announces Research Agreement with University of Maryland, Baltimore for Study
Tonix Pharmaceuticals Announces Research Agreement with University of Maryland, Baltimore, to Study TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Rejection in Heart Xenograft…
Read MoreAMPEL BioSolutions’ Breakthrough Predicts Drug Options for Fibromyalgia
CHARLOTTESVILLE, Va., Jan. 31, 2023 /PRNewswire/ -- AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat chronic pain syndromes,…
Read MoreDeka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application
GERMANTOWN, Md., Jan. 30, 2023 /PRNewswire/ -- Deka Biosciences ("Deka"), a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory…
Read MoreWBJ: Germantown’s Precigen raises $75M to advance treatments for rare diseases
Germantown’s Precigen Inc. (NASDAQ: PGEN) has raised $75 million in a public offering that closed Friday and intends to use the proceeds to speed…
Read More